Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDC25B | P30305 | 1/20 | 0.52 |
| ▸ | SLC15A1 | P46059 | 2/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | ALPI | P09923 | 1/20 | 0.47 |
| ▸ | PKM | P14618 | 1/20 | 0.47 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.47 |
| ▸ | XIAP | P98170 | 1/20 | 0.47 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.47 |
| ▸ | SLC1A1 | P43005 | 4/20 | 0.47 |
| ▸ | SLC1A3 | P43003 | 3/20 | 0.46 |
| ▸ | KIF11 | P52732 | 6/20 | 0.46 |
| ▸ | IDO1 | P14902 | 1/20 | 0.46 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2679262 | 1.00 | CDC25B (0.52) | CDC25BSLC15A1ALDH1A1MAPK1L3MBTL1 | |
| SCHEMBL7416182 | 0.86 | CDC25B (0.50) | CDC25BSLC15A1ALDH1A1MAPK1L3MBTL1 | |
| SCHEMBL7382091 | 0.86 | CDC25B (0.50) | CDC25BSLC15A1ALDH1A1MAPK1L3MBTL1 | |
| Methylamine SCHEMBL27674682 | 0.82 | CDC25B (0.47) | CDC25BSLC15A1ALDH1A1MAPK1L3MBTL1 | |
| SCHEMBL11185687 | 0.80 | PPARA (0.64) | SLC1A1SLC1A3IDO1 | |
| SCHEMBL4523936 | 0.80 | SLC15A1 (0.65) | SLC15A1ALDH1A1MAPK1L3MBTL1ALPI | |
| SCHEMBL730848 | 0.80 | SLC15A1 (0.65) | SLC15A1ALDH1A1MAPK1L3MBTL1ALPI | |
| SCHEMBL5898461 | 0.80 | SLC15A1 (0.65) | SLC15A1ALDH1A1MAPK1L3MBTL1ALPI | |
| SCHEMBL11852932 | 0.79 | ALDH1A1 (0.61) | CDC25BALDH1A1MAPK1L3MBTL1CYP2C19 | |
| SCHEMBL11714774 | 0.79 | SLC1A1 (0.58) | L3MBTL1ALPIPKMPTGS1XIAP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130022628-A1 | ACYL PSEUDOPEPTIDES WHICH CARRY A FUNCTIONALIZED AUXILIARY ARM | OM PHARMA (CH) | 2013-01-24 | — | — | US | disclosed |
| US-8173133-B2 | Acyl pseudodipeptides which carry a functionalized auxiliary arm | OM PHARMA (CH) | 2012-05-08 | — | — | US | disclosed |
| US-7799762-B2 | Acyl pseudodipeptides which carry a functionalised auxialiary arm | OM PHARMA (CH) | 2010-09-21 | — | — | US | disclosed |
| US-20100215685-A1 | ACYL PSEUDODIPEPTIDES WHICH CARRY A FUNCTIONALIZED AUXILIARY ARM | OM PHARMA (CH) | 2010-08-26 | — | — | US | disclosed |
| US-20050192232-A1 | Novel acyl-dipeptide-like compounds bearing an accessory functional side chain spacer, a method for preparing the same and pharmaceutical compositions containing such products | OM PHARMA (CH) | 2005-09-01 | — | — | US | disclosed |
| US-20030203852-A1 | Acyl pseudodipeptides which carry a functionalised auxialiary arm | OM PHARMA (CH) | 2003-10-30 | — | — | US | disclosed |
| CN-1434795-A | Acylated Pseudodipeptides with Functionalized Auxiliary Branches | OM PHARMA (CH) | 2003-08-06 | — | — | CN | disclosed |
| EP-1242365-A1 | ACYL PSEUDODIPEPTIDES WHICH CARRY A FUNCTIONALISED AUXILIARY ARM | OM Pharma (CH) | 2002-09-25 | — | — | EP | disclosed |
| WO-2001046126-A1 | ACYL PSEUDODIPEPTIDES WHICH CARRY A FUNCTIONALISED AUXILIARY ARM | OM PHARMA (CH) | 2001-06-28 | — | — | WO | disclosed |
| WO-2001046127-A1 | ACYL PSEUDOPEPTIDES BEARING A FUNCTIONALISED AUXILIARY SPACER | OM PHARMA (CH) | 2001-06-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050192232-A1 | Novel acyl-dipeptide-like compounds bearing an accessory functional side chain spacer, a method for preparing the same and pharmaceutical compositions containing such products | PIGS, AADAT, CD74 | CDC25B 4694/4885SLC15A1 766/4885ALDH1A1 3553/4885 |
| US-20030203852-A1 | Acyl pseudodipeptides which carry a functionalised auxialiary arm | PIGS, AADAC, ENPP2 | CDC25B 4105/4885SLC15A1 1023/4885ALDH1A1 4311/4885 |
| US-20100215685-A1 | ACYL PSEUDODIPEPTIDES WHICH CARRY A FUNCTIONALIZED AUXILIARY ARM | PIGS, DNPEP, ENPP2 | CDC25B 4722/4885SLC15A1 1734/4885ALDH1A1 4136/4885 |
| US-20130022628-A1 | ACYL PSEUDOPEPTIDES WHICH CARRY A FUNCTIONALIZED AUXILIARY ARM | PIGS, ENPEP, DNPEP | CDC25B 4768/4885SLC15A1 1597/4885ALDH1A1 4225/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.